Pablo Marcet Insider Profile

4 Followers
Pablo Marcet, Director at Interpace Diagnostics Group, holds 100.78K shares in Arcadium Lithium Plc (Ticker: ALTM), holds 0.00 shares in Livent (Ticker: LTHM), holds 9.39K shares in Interpace Diagnostics Group (Ticker: IDXG).
tipranks
Pablo Marcet

Pablo Marcet
Interpace Diagnostics Group (IDXG)
Director

Ranked #43,413 out of 99,335 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+10.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$555K
94.77%
5.23%
A breakdown of Pablo Marcet's holdings

Insider Roles

Arcadium Lithium Plc
(ALTM)
Director
Interpace Diagnostics Group
(IDXG)
Director
Roles that Pablo Marcet holds in companies

Most Profitable Insider Trade

Stock:
Arcadium Lithium Plc
(ALTM)
Rating:Informative Buy
Date:May 29, 2024 - Today
Return:+22.90%
The most profitable trade made by Pablo Marcet

Pablo Marcet's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Interpace Diagnostics Group
Feb 04, 2020
Director
Uninformative Buy
$29.02K
LTHM
Livent
Jan 08, 2024
Uninformative Sell
$0.00
Arcadium Lithium Plc
Jul 26, 2024
Director
Uninformative Buy
$526.06K
List of latest transactions for each holding click on a transaction to see Pablo Marcet's performance on stock

Pablo Marcet insider profile FAQ

What is the percentage of profitable transactions made by Pablo Marcet?
The percentage of profitable transactions made by Pablo Marcet is 50%.
    What is the average return per transaction made by Pablo Marcet?
    The average return per transaction made by Pablo Marcet is 10.30%.
      What stocks does Pablo Marcet hold?
      Pablo Marcet holds: IDXG, LTHM, ALTM stocks.
        What was Pablo Marcet’s latest transaction?
        Pablo Marcet latest transaction was an Uninformative Buy of ―.
          What was Pablo Marcet's most profitable transaction?
          Pablo Marcet’s most profitable transaction was an Informative Buy of ALTM stock on May 29, 2024. The return on the trade was 22.90%.
            What is Pablo Marcet's role in Interpace Diagnostics Group?
            Pablo Marcet's role in Interpace Diagnostics Group is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.